Elite Pharmaceuticals, Inc. (ELTP)
ELTP moved a median of -0.11% 30 minutes after news, and -1.60% by the close. How ELTP actually reacts to news — the realized, point-in-time move the market made, measured across 79 labeled events over the last three years with zero look-ahead.
ELTP’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.28% | 34% | 76 |
| 30-min | -0.11% | 42% | 78 |
| 60-min | -0.79% | 38% | 79 |
| to close | -1.60% | 37% | 78 |
| Middle 50% of ELTP reactions | -2.39% to +1.67% |
|---|---|
| Median reaction (30-min) | -0.11% |
| Measured reactions | 79 |
Half of all Elite Pharmaceuticals, Inc. news events land between -2.39% and +1.67% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ELTP moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ELTP's baseline. Nothing else.
Recent ELTP events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-Q ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.50% | +3.33% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | -3.50% | +3.33% | |
| Form 8-K/A ELITE PHARMACEUTICALS For: Aug 10 | SEC filing · Form 8-K | SEC EDGAR | +0.85% | -0.55% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | -1.18% | -3.47% | |
| Form 10-K ELITE PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | +1.22% | -7.62% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 29 | SEC filing · Form 8-K | SEC EDGAR | +1.22% | -7.62% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | +1.53% | -0.30% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 15 | SEC filing · Form 8-K | SEC EDGAR | +1.93% | +6.52% | |
| Form 8-K ELITE PHARMACEUTICALS For: May 29 | SEC filing · Form 8-K | SEC EDGAR | +1.45% | +3.78% | |
| Form 8-K ELITE PHARMACEUTICALS For: Apr 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.50% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -9.15% | -16.91% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 17 | SEC filing · Form 8-K | SEC EDGAR | -9.15% | -16.91% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.75% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.70% | -8.38% | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | -1.70% | -8.38% | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +1.23% | +3.96% | |
| Form 8-K/A ELITE PHARMACEUTICALS For: Nov 10 | SEC filing · Form 8-K | SEC EDGAR | -1.92% | — | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 10 | SEC filing · Form 8-K | SEC EDGAR | -1.32% | -0.81% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.57% | -11.04% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -1.57% | -11.04% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 08 | SEC filing · Form 8-K | SEC EDGAR | +0.86% | -1.74% | |
| Form 10-K ELITE PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | -3.32% | -13.97% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | -3.32% | -13.97% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | +6.36% | +1.08% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | +4.07% | +4.22% | |
| Form 8-K ELITE PHARMACEUTICALS For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | +2.36% | +1.19% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 28 | SEC filing · Form 8-K | SEC EDGAR | -2.04% | -1.53% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +1.09% | +17.75% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 13 | SEC filing · Form 8-K | SEC EDGAR | +1.09% | +17.75% | |
| Form 8-K ELITE PHARMACEUTICALS For: Dec 26 | SEC filing · Form 8-K | SEC EDGAR | -0.54% | +0.41% | |
| Form 8-K ELITE PHARMACEUTICALS For: Dec 02 | SEC filing · Form 8-K | SEC EDGAR | -0.60% | -2.74% | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 18 | SEC filing · Form 8-K | SEC EDGAR | -2.94% | -3.56% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.89% | +12.32% | |
| Form 8-K ELITE PHARMACEUTICALS For: Nov 14 | SEC filing · Form 8-K | SEC EDGAR | -1.89% | +12.32% | |
| Form 8-K ELITE PHARMACEUTICALS For: Oct 10 | SEC filing · Form 8-K | SEC EDGAR | -1.21% | +4.75% | |
| Form 8-K ELITE PHARMACEUTICALS For: Oct 07 | SEC filing · Form 8-K | SEC EDGAR | +1.54% | +1.18% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | +2.70% | +9.04% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.31% | -3.97% | |
| Form 8-K ELITE PHARMACEUTICALS For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -1.31% | -3.97% | |
| Form 10-K ELITE PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | -0.02% | -10.74% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jul 01 | SEC filing · Form 8-K | SEC EDGAR | -0.02% | -10.74% | |
| Form S-8 ELITE PHARMACEUTICALS | SEC filing · Form S-8 | SEC EDGAR | -0.02% | -10.74% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | +6.10% | +7.99% | |
| Form 8-K ELITE PHARMACEUTICALS For: Jun 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +4.69% | |
| Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate | Press release | Accesswire | -2.35% | -0.81% | |
| Form 8-K ELITE PHARMACEUTICALS For: May 20 | SEC filing · Form 8-K | SEC EDGAR | -1.12% | +0.74% | |
| Form S-8 ELITE PHARMACEUTICALS | SEC filing · Form S-8 | SEC EDGAR | -0.39% | -1.67% | |
| Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information | Press release | Accesswire | -3.56% | -11.06% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -3.56% | -11.06% | |
| Form 8-K ELITE PHARMACEUTICALS For: Feb 14 | SEC filing · Form 8-K | SEC EDGAR | -3.56% | -11.06% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ELTP section they belong to.
Where else ELTP is measured.
ELTP earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Homology Medicines, Inc. (FIXX) | 80 | -0.34% | 33% |
| Orchard Therapeutics plc - American Depositary Shares (ORTX) | 80 | +0.06% | 66% |
| Genetic Technologies Ltd - American Depositary Shares (GENE) | 79 | -0.05% | 33% |
| MOTIF BIO PLC ADRS (MTFB) | 79 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Elite Pharmaceuticals, Inc.'s median reaction calculated?
Every labeled ELTP news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 79 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 42% of ELTP's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ELTP's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.